Menu
Chairman
Surgical Oncologist
MBBS MD FRACS FAMS FACS
Professor Duke-NUS Medical School
Visiting Consultant NCCS and SGH
Khee Chee studied medicine in the University of Singapore graduating in 1975. He did his surgical training in Sydney and then had his fellowship training in surgical oncology and head and neck surgery in London and New York. He returned to Singapore General Hospital in 1988 and has been there since. In 1993 he became Head of the Department of Surgery and held that position for 11 years. He was for a period Chair of the NUS Department of Surgery. In 1997 he became the Founding Director of the National Cancer Centre Singapore and recently retired from that position after 20 years. He was also the Senior Vice Dean of Duke NUS Medical School and now continues to hold the Benjamin Sheares Professorship in Academic Medicine. He has just started his own surgical practice in Farrer Park Hospital.
In his career in Singapore spanning 30 years, he has trained numerous general surgeons, surgeons with interest in cancer surgery and head and neck surgery. In that period of time he has the pleasure of seeing many of these specialties have become recognised as leading practitioners in their respective fields in Singapore and regionally.
He has been recognised as the pioneer and leading cancer surgeon in the country. He introduced complex surgery like peritonectomies for previously inoperable cancers in the abdominal cavity and major intraabdominal tumours including removal of invaded major blood vessels. In the field of head and neck surgery, he is recognised to have performed the most of complex operations for cancers in this region. He is also recognised for removal of limb soft tissue tumours. He also introduced isolated limb perfusion for the management of intransit metastases for skin tumours attempting to salvage limbs which would otherwise require amputations.
He has also won several national awards including Public Adminstration (Gold), National Outstanding Mentor and the President’s Science and Technology Award. He is currently the Inaugural Benjamin Shears Professor in Academic Medicine for Duke-Nus Medical School.
Director
Dr Melvin Chua is a Clinician-Scientist at the National Cancer Centre Singapore, and Principal Investigator of the Tan Chin Tuan Laboratory of Optical Imaging, Photodynamic and Proton Beam Therapy – Precision Radiation Oncology Programme, He is also the Head of Department and Senior Consultant for Head and Neck and Thoracic Cancers, Division of Radiation Oncology and Director of the Data and computational Science Core. His research is supported by the NMRC Clinician-scientist award, and is focused on discovery and translational cancer genomics, and the development of biomarker-directed clinical trials in nasopharyngeal (NPC) and prostate cancers.
He graduated from the Yong Loo Lin School of Medicine, National University Singapore in 2002. He obtained his Fellowship in Clinical Oncology from the Royal College of Radiologists, and his Doctorate from the University College London in 2013. He later completed post-doctoral Clinician-scientist fellowships at the Mount Vernon Cancer Centre, UK, and the Princess Margaret Cancer Center, Toronto. In the year of 2021, he obtained his fellowship of the Academy of Medicine Singapore under the College of Radiation Oncology and Clinician Scientists.
Dr Chua is a KOL on NPC and prostate cancer, and he has been invited to speak at more than 100 international meetings. He is also on the scientific advisory board for the NPC Guangzhou-Singapore Trial Network, a board member on the Head Neck Cancer International Group (HNCIG) and the Scientific Committee Chair of HNCIG Artificial Intelligence working group.
His other academic activities include his roles as the Associate Senior Editor of the International Journal of Radiation Oncology Biology Physics – Official journal of the American Society of Radiation Oncology and Editor-in-Chief, Annals of Nasopharynx Cancer. He also serves on the International Education Steering Group and the Asia-Pacific Regional Council of the American Society of Clinical Oncology (ASCO). He has published over 100 peer-reviewed papers, with a H-index of 29, including highly cited articles in the New England Journal of Medicine, Lancet, Nature, Cell, Journal of Clinical Oncology and JAMA Oncology.
Director
Dr Guy Heathers is currently VP Business Development at Hummingbird Bioscience as well as consultant to a number of Singapore biotech companies and former Director of Technology Development at the National Cancer Centre, Singapore and Director of SingHealth IP office. Previously Guy held a number of positions in the bioscience field in different continents including: CBO at Cancer Therapeutics CRC Pty Ltd, Melbourne Australia; CEO at Amaranth Medical Pte Ltd (Singapore), Gateway Capital Pty Ltd (Australia) and Biotech Research Ventures Pte Ltd (Singapore). Earlier in his career he held positions of Chief Operating Officer, Cancer Research Ventures Ltd and Head of Business Development, Cancer Research Campaign Technology Ltd. He started his business career with 7 years of drug discovery management at Hoffmann-La Roche in Nutley, NJ, USA, across a number of therapeutic areas. In addition to these roles, Guy has been instrumental in creating and developing over 20 biotech start-ups during his career, including Cyclacel (listed on NASDAQ), Kudos (bought by Astra Zeneca) and Enleofen (bought by Boehringer Ingelheim) as well as numerous multi-million dollar international licensing and collaboration deals in the biotechnology industry.
Managing Director and Group Chief Executive Officer
Eddie is currently the Managing Director of DISA Limited overseeing DISA’s growth and executes strategies by developing infrastructure, processes and applications through the deployment of new digital solutions. He has been seeking development opportunities proactively to capitalise the benefits of digitalisation.
Prior to joining DISA, Eddie held leadership roles in diverse fields on product research and development, innovation, marketing and sales. He was with Metech International Limited as its irector and Interim/Acting CEO, was an executive director of LifeBrandz Ltd. and an independent director of AGV Group Limited. Mr. Chng was awarded Asia Europe Entrepreneurs Award at the Berlin Asia Europe Young Entrepreneurs Forum.
Director
Martin Lavoo is currently working as a Portfolio Manager at Wu Advisors Pte. Ltd. and Managing Director of Nipsea International Limited, where he manages both public and private investments for the Wuthelam Group of companies, a leading Asian paint and coating company.
He is also the co-founder and Executive Director of Sustenir Group Pte Ltd, which today is one of Asia’s leading vertical farms with operations across Singapore, Hong Kong, and Malaysia. Prior to founding Sustenir, Martin was with Riverbed Technology Inc. as a Regional Sales Manager of North Asia and worked as an audit associate at KPMG at the start of his career.
Martin is an MBA graduate from the University of Chicago Booth School of Business and holds an undergraduate degree in Accounting & Management from the University of New South Wales.
Director
Mr. Wong was a General Partner at General Atlantic Partners, LLC, a worldwide private equity firm, and the Group Managing Director for Hong Leong Corporation. Previously, he was also the Chairman of TSH Corporation Limited, Vice Chairman of China Yuchai Ltd, Managing Director of IBM Singapore, Sri Lanka and Brunei, a Trustee of Singapore Management University, and a Director of the Singapore Institute of Management, Asia Dekor Holdings Limited, Asia Dekor Pte Ltd and Goodpack Limited.
Mr. Wong holds a MBA from Brunel University (UK) and completed the Advanced Management Programme at the University of Hawaii.
Executive Director
Yang Kwang is the Chief Executive Officer of the Company, managing the manufacturing and sales activities across the Company.
Yang Kwang is also the Chief Executive Officer of DiSa Digital Safety Pte. Ltd. overseeing the overall operations of DiSa Digital Safety (Shenzhen) Limited and DiSa Digital Safety (USA). He has been engaged in the manufacturing industry for more than 20 years. He started his career with Hewlett Packard and Texas Instruments and holds a Bachelor of Electrical and Electronics Engineering from National University of Singapore.